cagrilintide and semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit REDEFINE 1 Trial Finds Cagrilintide–Semaglutide

Especially not one that tamps down something as ancient as hunger

If the redness is expanding rather than stable, contact your prescribing provider within 24 hours

Since it supports our bodies in many ways, not getting enough protein can lead to your body breaking down things like hair and muscle tissue to get the protein it needs

Cheri is extremely knowledgeable and takes the time to listen

EC review and approval CEC is the only ethics body involved in the review process

3,8 To help clinicians navigate discontinuation after patients achieve their weight loss goals, and given the absence of robust evidence or guidelines, we propose three discontinuation strategies: dose de-escalation, interval dosing, and the add-on strategy (Table 1)